longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

ETRACS 2x Lvrgd MSCI US Qlty Fctr TR ETN

QULL

----
Start trading
OverviewOverviewNewsNewsPostsPostsWikiWikiRatingsRatingsCompositionCompositionDividendsDividends
LongbridgeAI
  • Weekly Recap | Apple +3.84%, most brokers rate it buy

    Weekly Review·2 days ago, 07:40 AM
    - Apple shares rose 3.84 % over four trading days to close at $ 332.27, outperforming the S & P 500 amid market attention driven by the launch of the iPhone 18 series and the foldable iPhone Duo. - A consensus rating of buy is maintained by most of the 46 institutions, though the average target price of $ 325.66 sits slightly below the current price with significant divergence. - Future performance will depend on the upcoming iPhone 18 Pro pre-order data and macroeconomic consumption reports to test high-valuation tech stocks.
    AAPL+0.24%AAPB+0.47%
  • Weekly Recap | TJX -4.59%, fresh 52-week lows

    Weekly Review·2 days ago, 06:52 AM
    TJX-0.02%
  • Weekly Recap | NVIDIA -5.24%, consensus target above spot

    Weekly Review·2 days ago, 06:27 AM
    - Nvidia stock fell 5.24 % over the week to close at 218.29 dollars, underperforming the S&P 500 by about 4.44 percentage points amid declining trading volume. - Key focal points included discussions on domestic AI chip competition following a rival firm's market debut, CEO remarks at a technology conference, and reports regarding potential investment in Anthropic. - Institutional sentiment remained largely positive, with 48 buy ratings and a consensus target price of 327.18 dollars, which sits roughly 49.88 % above the current share price.
    NVDA-3.36%NVDD+3.33%
  • Weekly Recap | Microsoft -0.81%, most brokers rate it buy

    Weekly Review·2 days ago, 06:23 AM
    - Microsoft's stock fell 0.81 % to close at 495.63 dollars with light trading volume, while the company advanced its data center expansion and educational AI safety initiatives. - Among 55 covering institutions, 38 rated the stock a buy and 14 gave an overweight rating, yielding a consensus target price of 572.92 dollars. - Future performance will depend on upcoming macroeconomic data releases and the execution timeline of the company's data center computing capacity plans.
    MSFT+1.97%MSFD-1.97%
  • Weekly Recap | Meta Platforms +5.07%, most brokers rate it buy

    Weekly Review·2 days ago, 06:20 AM
    - Meta closed up 5.07 % at 648.03 USD this week, outperforming the S & P 500 index amidst active trading volume. - The company advanced AI agent commercialization by introducing consumer subscription pricing and receiving positive institutional feedback. - Wall Street maintained a strong buy consensus with an average target price of 758.28 USD, while monitoring ongoing organizational restructuring and monetization progress.
    META+2.71%FBL+5.43%
  • Weekly Recap | Eli Lilly -2.93%, closing $3.8 billion deal

    Weekly Review·2 days ago, 06:15 AM
    LLY+2.02%LLYX+4.02%
  • Weekly Recap | KLA -2.67%, consensus target above spot

    Weekly Review·2 days ago, 06:10 AM
    KLAC-6.39%
  • Weekly Recap | Applied Materials +0.39%, AI demand supports a positive week

    Weekly Review·2 days ago, 05:57 AM
    AMAT-7.07%
  • Weekly Recap | QUAL.US -1.07%, closing in on record highs

    Weekly Review·2 days ago, 04:49 AM
    QUAL-0.02%QULL0.00%
  • Weekly Recap | Microsoft -2.69%, sliding back below $500

    Weekly Review·Sep 5 at 07:27 AM
    - Microsoft stock declined 2.69 % over the week to close at 499.70 dollars, falling below the 500 dollars threshold amid volatile trading and lighter volume. - Key developments included a business reorganization to separately disclose Azure revenue projecting 44 % to 45 % growth, new copyright lawsuits, and product updates. - Institutional sentiment remained strong with a consensus rating of strong buy and an average target price of 572.92 dollars, while upcoming macroeconomic data remains in focus.
    MSFT+1.97%MSFD-1.97%
  • Weekly Recap | Eli Lilly -2.15%, most brokers rate it buy

    Weekly Review·Sep 5 at 07:19 AM
    LLY+2.02%LLYX+4.02%
  • Weekly Recap | Eli Lilly -6.44%, FDA clears Mounjaro heart-risk label

    Weekly Review·Aug 29 at 05:57 AM
    LLY+2.02%LLYX+4.02%
  • Weekly Recap | Eli Lilly +6.38%, closing in on record highs

    Weekly Review·Aug 22 at 05:14 AM
    LLY+2.02%LLYX+4.02%